Phathom Pharmaceuticals, Inc. (PHAT) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Hello, and welcome to Fathom Pharmaceuticals' fourth quarter and full year 2025 earnings results call. At this time, all participants are in a listen-only mode. After the presentation, there will be a question and answer session. To ask a question, please press star 1-1 on your telephone keypad. Please be advised that today's call is being recorded. With that, I would like to turn the call over to Eric Chiarelli, Fathom's Head of Investor Relations. Please go ahead. Thank you, operator. Hello, everyone, and thank you for joining us this morning to discuss Fathom's fourth quarter and full year 2025 results. This morning's presentation will include remarks from Steve Basta, our president and CEO, and Sanjeev Nallula, our chief financial and business officer. A couple of notes before we get started. Earlier this morning, we issued a press release detailing the results we'll be discussing during the call. A copy of that press release can be found under the news releases section of our corporate website. Further, the recording of today's webcast and the slides we'll be reviewing can also be found on our corporate website under the Events and Presentations section. Before we begin, let me remind you that we'll be making a number of forward-looking statements throughout today's presentation. These forward-looking statements involve risks and uncertainties, many of which are beyond Fathom's control. Actual results may materially differ from the forward-looking statements, and any such risks may materially adversely affect our business and results of operations and the trading prices for Fathom's common stock. A discussion of these statements and risk factors is available in the current Safe Harbor slide, as well as in the risk factors section of our most recent Form 10-K and...